Literature DB >> 11043643

Outbreak of Rift Valley fever--Saudi Arabia, August-October, 2000.

.   

Abstract

On September 10, 2000, the Ministry of Health (MOH), Kingdom of Saudi Arabia, and subsequently the Ministry of Health of Yemen received reports of unexplained hemorrhagic fever in humans and associated animal deaths from the southwestern border of Saudi Arabia and Yemen. Signs and symptoms of ill persons included low grade fever, abdominal pain, vomiting, diarrhea, jaundice with liver and renal dysfunction often progressing to disseminated intravascular coagulation, hepatorenal syndrome, and death. On September 15, using ELISA (antigen detection and IgM), polymerase chain reaction, virus isolation, and immunohistochemistry, CDC confirmed the diagnosis of Rift Valley fever (RVF) in all four serum samples submitted from Saudi Arabia. This report summarizes the preliminary results of the collaborative epidemiologic investigation performed by the Saudi Arabian MOH, CDC, and the National Institute of Virology, South Africa, of the first confirmed occurrence of RVF outside Africa.

Entities:  

Mesh:

Year:  2000        PMID: 11043643

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  43 in total

1.  Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.

Authors:  S Garcia; J M Crance; A Billecocq; A Peinnequin; A Jouan; M Bouloy; D Garin
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever.

Authors:  A A Sall; E A Macondo; O K Sène; M Diagne; R Sylla; M Mondo; L Girault; L Marrama; A Spiegel; M Diallo; M Bouloy; C Mathiot
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  J Biomol Screen       Date:  2012-05-29

5.  Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

6.  Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia.

Authors:  Ziad A Memish; Malak A Masri; Benjamin D Anderson; Gary L Heil; Hunter R Merrill; Salah U Khan; Ahmad Alsahly; Gregory C Gray
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

7.  Real-time reverse-transcription loop-mediated isothermal amplification for rapid detection of rift valley Fever virus.

Authors:  Christophe N Peyrefitte; Laetitia Boubis; Daniel Coudrier; Michèle Bouloy; Marc Grandadam; Hugues J Tolou; Sébastien Plumet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

8.  Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.

Authors:  Myrna M Miller; Kristine E Bennett; Barbara S Drolet; Robbin Lindsay; James O Mecham; Will K Reeves; Hana M Weingartl; William C Wilson
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

9.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia.

Authors:  Barry R Miller; Marvin S Godsey; Mary B Crabtree; Harry M Savage; Yagob Al-Mazrao; Mohammed H Al-Jeffri; Abdel-Mohsin M Abdoon; Suleiman M Al-Seghayer; Ali M Al-Shahrani; Thomas G Ksiazek
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.